Government ❯ Regulatory Agencies ❯ FDA

Drug Approval

Mifepristone Mifepristone Regulations Psychedelic Drugs Telehealth Regulations Supply Chain Management Opioid Test FDA Regulations Medicine Regulation Legal Challenges Safety Evaluation Public Health Leucovorin Approval Prescription Drugs Online Prescribing Services Risk Management Safety Regulations Mifepristone Regulation Vaccines Advertising Regulations Sunscreen Ingredients Clinical Trials Emergency Use Authorization MDMA Regulations Safety Monitoring

Securities Class Action Filed Against ImmunityBio After FDA Flags Anktiva Marketing

Law firms are vying to lead the case before a May 26 deadline for investors.

Hawley Seeks Congressional Oversight of Mifepristone After FDA Offers No Timeline on Safety Review

Republicans Push to Restore In‑Person Rules for Abortion Pill at Fiery Senate Hearing

FDA Halts Sales of Unapproved Ingestible Fluoride for Children 3 and Under

Cytokinetics Hit With Securities Class Action Over Aficamten Timeline Disclosures